EMT and MET: necessary or permissive for metastasis?

MK Jolly, KE Ware, S Gilja, JA Somarelli… - Molecular …, 2017 - Wiley Online Library
Epithelial‐to‐mesenchymal transition ( EMT ) and its reverse mesenchymal‐to‐epithelial
transition ( MET ) have been suggested to play crucial roles in metastatic dissemination of …

Fibroblast growth factor (FGF) and FGF receptor-mediated autocrine signaling in non-small-cell lung cancer cells

L Marek, KE Ware, A Fritzsche, P Hercule… - Molecular …, 2009 - ASPET
Despite widespread expression of epidermal growth factor (EGF) receptors (EGFRs) and
EGF family ligands in non-small-cell lung cancer (NSCLC), EGFR-specific tyrosine kinase …

[HTML][HTML] Rapidly acquired resistance to EGFR tyrosine kinase inhibitors in NSCLC cell lines through de-repression of FGFR2 and FGFR3 expression

KE Ware, ME Marshall, LR Heasley, L Marek, TK Hinz… - PloS one, 2010 - journals.plos.org
Despite initial and sometimes dramatic responses of specific NSCLC tumors to EGFR TKIs,
nearly all will develop resistance and relapse. Gene expression analysis of NSCLC cell lines …

FGFR1 mRNA and protein expression, not gene copy number, predict FGFR TKI sensitivity across all lung cancer histologies

…, TK Hinz, D Gao, M Martini, LA Marek, KE Ware… - Clinical cancer …, 2014 - AACR
Purpose: FGFR1 gene copy number (GCN) is being evaluated as a biomarker for FGFR tyrosine
kinase inhibitor (TKI) response in squamous cell lung cancers (SCC). The exclusive use …

[HTML][HTML] Biologic and clinical significance of androgen receptor variants in castration resistant prostate cancer

KE Ware, MA Garcia-Blanco… - Endocrine-related …, 2014 - erc.bioscientifica.com
As prostate cancer (PCa) progresses to the lethal castration resistant and metastatic form,
genetic and epigenetic adaptation, clonal selection, and evolution of the tumor …

Fibroblast growth factor receptors are components of autocrine signaling networks in head and neck squamous cell carcinoma cells

…, SA Kono, KR Singleton, B Bichon, KE Ware… - Clinical cancer …, 2011 - AACR
Purpose: We previously reported that a fibroblast growth factor (FGF) receptor (FGFR) signaling
pathway drives growth of lung cancer cell lines of squamous and large cell histologies. …

Mesenchymal-epithelial transition in sarcomas is controlled by the combinatorial expression of microRNA 200s and GRHL2

…, AJ Hish, S Gilja, WC Eward, KE Ware… - … and cellular biology, 2016 - Taylor & Francis
Phenotypic plasticity involves a process in which cells transiently acquire phenotypic traits
of another lineage. Two commonly studied types of phenotypic plasticity are epithelial-…

EGFR mediates responses to small-molecule drugs targeting oncogenic fusion kinases

…, MA Smith, S Kako, NJ Sumi, KD Davies, KE Ware… - Cancer research, 2017 - AACR
Oncogenic kinase fusions of ALK, ROS1, RET, and NTRK1 act as drivers in human lung and
other cancers. Residual tumor burden following treatment of ALK or ROS1 + lung cancer …

Whole genomic copy number alterations in circulating tumor cells from men with abiraterone or enzalutamide-resistant metastatic castration-resistant prostate cancer

…, RL Bitting, J Beaver, JA Somarelli, KE Ware… - Clinical Cancer …, 2017 - AACR
Purpose: Beyond enumeration, circulating tumor cells (CTCs) can provide genetic information
from metastatic cancer that may facilitate a greater understanding of tumor biology and …

E-cadherin represses anchorage-independent growth in sarcomas through both signaling and mechanical mechanisms

MK Jolly, KE Ware, S Xu, S Gilja, S Shetler… - Molecular Cancer …, 2019 - AACR
… MK Jolly and KE Ware contributed equally to and are the co-first authors of this article. …
Because membrane E-cadherin is the most typically characterized aspect of E-cadherin function, …